On September 8, 2026, CNBC reported that AstraZeneca PLC (NYSE:AZN) released full results from two successful late-stage ...
Tempus AI (NASDAQ:TEM | TEM Price Prediction) is having a breakout week after Morgan Stanley remarks on September 15 ...
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Shionogi as a shareholder, today announced the ...
Alkermes plc (Nasdaq: ALKS) today announced the appointment of a new independent director, Anne C. Whitaker, to the company’s ...
Turbett Surgical, a leader in innovative sterilization and operating room efficiency solutions, today announced the appointment of Jennifer Scalise-Mullett, J.D. as the company’s new Vice President, ...
GSK plc (NYSE:GSK) plans to close its vaccine manufacturing facility in Dresden, Germany, by summer 2027, putting 641 jobs at risk.
Pharmaceutical Technology on MSN
GSK bolsters oncology pipeline with $750m Chimagen TCE deal
GSK plans to take the TCE to Phase I clinical trials in multiple myeloma during 2027.
GSK says it has struck a deal to acquire a promising T-cell asset, while Kier Group's annual profit beat consensus. Here is what you need to know before the London market open: FTSE 100: called 0.2% ...
The sector’s weakness followed a renewed rise in British government borrowing costs. The benchmark 10-year gilt yield moved ...
As of Tuesday, September 15, Ionis Pharmaceuticals, Inc.’s IONS share price has dipped by 5.02%, which has investors ...
GSK said on Friday it will be shutting down a vaccine factory in Dresden, Germany, in the summer of 2027, citing decreasing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results